Risk Sharing Work Group issue brief providing an overview of the various risk-sharing mechanisms in the ACA and the risks each mechanism can mitigate. (
)
Medicare Steering Committee's annual issue brief offering an actuarial perspective on Medicare's financial condition and outlining the public policy options to address the program's long-term financial challenges. (
)
Medicare Steering Committee issue brief that summarizes the key cost, access, and quality issues associated with some of the Medicare-related provisions in the various debt and deficit reduction proposals. (
)
Medicare Steering Committee annual issue brief offering an actuarial perspective on Medicare's financial condition and outlining the public policy options to address the program's long-term financial challenges. (
)
Health Practice Council issue brief providing an overview of risk adjustment and outlining general considerations for implementing a risk adjustment mechanism under PPACA. (
)
Medicare Steering Committee issue brief describing the current payment system, providing an overview of the goals of the Medicare Advantage program and addressing two of the alternative mechanisms (and some variations) for reducing payments to Medicare Advantage plans. (
)
Health Care Quality Work Group issue brief defining value-based insurance design (VBID), providing an overview of its prevalence, examining barriers to implementation, and reviewing policy considerations. (
)
Medicare Steering Committee annual issue brief offering an actuarial perspective on Medicare's financial condition and outlining public policy options to address the program's long-term financial challenges. (
)
Task Force on Genetic Testing in Health Insurance issue brief reviewing the fundamentals of risk selection and risk classification to help policymakers and the public better understand the role that risk classification plays in the voluntary individual health insurance market. (
)
Health Care Quality Work Group issue brief discussing current assessments of health care quality, the process for incorporating new treatment protocols and technologies into health insurance coverage, and the policy implications of comparative effectiveness research. (
)